Displaying 69 UK Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Pheon Therapeutics HIRING

Antibody-Drug Conjugate specialist creating treatments for tough-to-treat cancers.

79
$120M · Series B TCG Crossover, Atlas Ventures, Brandon Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@pheontx.com
CN BioJUST ADDED HIRING

Provider of single and multi-organ microphysiological systems.

68
$21M · Series B CN Innovations 101 to 250 Health Tech, Biotech London, UK •••••••••••@cn-bio.com
Causaly

Biomedical research discovery tool.

64
$60M · Series B ICONIQ Growth, Index Ventures, Pentech Ventures 51 to 100 Health Tech, AI, Biotech, Pharma B2B, SaaS London, UK •••••••••••@causaly.com
Apollo Therapeutics

Portfolio of pharmaceutical research and discovery.

64
$33M · Series C Patient Square Capital, Rock Springs Capital, M&G Investments 1 to 10 Biotech, Pharma London, UK •••••••••••@apollotherapeutics.com
Baseimmune

AI vaccine algorithm developer.

64
$11M · Series A Hoxton Ventures, Merck Global Health Innovation Fund, Cherry Ventures 1 to 10 AI, Biotech B2B, SaaS London, UK •••••••••••@baseimmune.co.uk
Beacon Therapeutics

Oophthalmic gene therapy company to treat blinding retinal illnesses.

64
$120M · Series A Syncona Partners LLP 1 to 10 Health Tech, Biotech London, UK •••••••••••@beacontx.com
IMU Biosciences

AI platform to map the human immune system.

59
$14M · Series A Life Extension Ventures, Molten Ventures 11 to 50 Health Tech, Biotech London, UK •••••••••••@imubiosciences.com
FA Bio

Discovery and development platform of superior microbial bioproducts.

59
$6M · Series A Pymwymic, Clean Growth Fund 1 to 10 Biotech London, UK •••••••••••@fungialert.com
Mytos

Fully-automated cell manufacturing.

59
$19M · Series A Buckley Ventures, Wing Venture Capital, IQ Capital Partners 11 to 50 Biotech, Machine Learning B2B London, UK •••••••••••@mytos.bio
Stanhope AI

Neuroscience-driven AI platform.

59
$2M · Seed Rockmount Capital, UCL Technology Fund, Moonfire Ventures 11 to 50 AI, Biotech B2B, SaaS London, UK •••••••••••@stanhopeai.com
SparxellJUST ADDED

Developer of sustainable plant-based pigments.

59
$3M · Seed PDS Ventures, Circular Innovation Fund, L'Oreal 1 to 10 Biotech, Manufacturing B2C London, UK •••••••••••@sparxell.com
Hexigone InhibitorsJUST ADDED HIRING

Sustainable corrosion inhibitors manufacturer.

59
$1M · Seed Oxford Innovation Finance, Waterspring Ventures, Development Bank of Wales 1 to 10 Biotech, Manufacturing B2B London, UK •••••••••••@hexigone.com
Complement Therapeutics

Preclinical stage treatment for geographic atrophy.

59
$78M · Series A Forbion Capital Partners, Gimv 1 to 10 Biotech London, UK •••••••••••@complementtx.com
MIP Discovery

Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies.

59
$8M · Series A Mercia Asset Management 11 to 50 Health Tech, Biotech London, UK •••••••••••@mipdiscovery.com
Umedeor

Platform to automate the clinical studies process.

54
$12M · Series A Playfair, Delin Ventures, 11.2 Capital 11 to 50 Health Tech, Biotech B2B London, UK •••••••••••@umed.io
Laverock Therapeutics

Gene silencing platform for the creation of programmable, allogeneic cell therapies.

54
$16M · Seed Mercia Asset Management, Calculus Capital, UK Innovation & Science Seed Fund 1 to 10 Health Tech, Biotech London, UK •••••••••••@laverocktx.com
Ori Biotech

Manufacturing platform designed to help patients access lifesaving treatments.

54
$30M · Series A Kindred Capital, Octopus Ventures, Amadeus Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B London, UK •••••••••••@oribiotech.com
Hypervision Surgical

Precision software for eye surgery.

54
$8M · Seed Redalpine 1 to 10 Health Tech, Biotech London, UK •••••••••••@hypervisionsurgical.com
Flarin

Patent-protected anti-inflammatory painkiller.

54
$6M · Series A ITV AdVentures 1 to 10 Biotech, Pharma B2C London, UK •••••••••••@flarin.co.uk
Lindus Health

Clinical trials platform.

54
$18M · Series A Valar Ventures, Creandum, Seedcamp 11 to 50 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@lindushealth.com
Genomes

User-owned genomics database platform.

54
$20M · Series A GEM Digital 1 to 10 Health Tech, Biotech B2C London, UK •••••••••••@genomes.io
Charm Therapeutics

Platform using deep learning on 3D molecular structures to develop treatments for harmful proteins.

54
$50M · Series A Khosla Ventures, General Catalyst 1 to 10 Health Tech, AI, Biotech, Data and Analytics B2B London, UK •••••••••••@charmtx.com
Tropic Biosciences

Platform specializing in developing new, high-yield tropical crop varieties and traits.

54
$28M · Series B Future Planet Capital 11 to 50 Agritech, Biotech, Deep Tech, Manufacturing B2B London, UK •••••••••••@tropicbioscience.com
Quell Therapeutics

Cell therapy firm specializing in developing treatments using advanced cellular technology.

54
$45M · Series A AlbionVC, Point72 Ventures 101 to 250 Health Tech, Edtech, Biotech, Manufacturing B2B London, UK •••••••••••@quell-tx.com
ReViral

Biotechnology firm developing antiviral treatments for patients.

54
$44M · Series C Novo A/S, Andera Partners 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@reviral.co.uk
Sable bio

AI-powered drug testing platform.

50
$1M · Pre Seed Seedcamp, Episode 1 1 to 10 AI, Biotech London, UK •••••••••••@sablebio.com
Kuano

Quantum simulation platform for drug discovery.

50
$2M · Seed Ascension Ventures, ACF Investors 1 to 10 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@kuano.ai
Pathfinder Medical

Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.

50
$11M · Series A Business Growth Fund, Deepbridge Capital, Parkwalk Advisors 1 to 10 Health Tech, Biotech, Manufacturing B2B London, UK •••••••••••@pathfindermed.com
Opencell

Biotech lab spaces housed in shipping containers to make biotechnology accessible and affordable.

50
$8M Seventure Partners 1 to 10 Fintech, Biotech, Proptech & Real Estate, Manufacturing B2B, SaaS London, UK •••••••••••@opencell.bio
Pear Bio

Cancer treatment predictor software.

50
$14M · Series A Hoxton Ventures, Octopus Ventures, Fly Ventures 11 to 50 Health Tech, Biotech, Pharma B2B London, UK •••••••••••@pearbio.com
Basecamp Research

Protein discovery research and manufacturing.

50
$19M · Series A SYSTEMIQ 11 to 50 Biotech, Deep Tech London, UK •••••••••••@basecamp-research.com
Sixfold Bioscience

Biotechnology firm focused on advancing RNA therapies.

50
$10M Y Combinator, Pi Campus 11 to 50 Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence B2B London, UK •••••••••••@sixfold.bio
Multiomic Health

Precision therapeutics discovery platform.

50
$6M · Seed Hoxton Ventures 11 to 50 Biotech B2B London, UK •••••••••••@multiomic.uk
Bea Fertility

At-home fertility treatment.

50
$3M · Seed Octopus Ventures, Calm/Storm Ventures, QVentures 1 to 10 Health Tech, Biotech B2C London, UK •••••••••••@beafertility.com
Daye

Gynecological health company creating products and services for vaginal treatment.

50
$5M · Seed Khosla Ventures, Index Ventures, Kindred Capital 11 to 50 Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis B2C London, UK •••••••••••@yourdaye.com
Myricx Pharma

Drug discovery platform focused on developing small molecule inhibitors.

50
$6M · Seed Sofinnova Partners 1 to 10 Health Tech, Biotech, Deep Tech, Pharma B2B London, UK •••••••••••@myricxpharma.com
Achilles Therapeutics

Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.

50
$17M · Seed AlbionVC, Boxer Capital, Syncona Partners LLP 101 to 250 Health Tech, Biotech B2B London, UK •••••••••••@achillestx.com
ImmuONE

3D human lung model developer.

50
$2M · Seed Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund 11 to 50 Biotech, Deep Tech London, UK •••••••••••@immuone.com
InfinitopesJUST ADDED HIRING

Developer of vaccines for the treatment of cancer.

46
$16M · Seed Octopus Ventures, Martlet Capital, Cancer Research Institute 1 to 10 Health Tech, Biotech B2C Oxford, UK •••••••••••@infinitopes.com
PlaqueTecJUST ADDED HIRING

Bioinformatics discovery platform.

46
$8M · Series A Future Fund 1 to 10 Biotech, Data and Analytics B2B, SaaS Cambridge, UK •••••••••••@plaquetec.com
Puraffinity

Platform for developing materials that precisely target and remove harmful chemicals like PFAS from water.

43
$3M · Seed Kindred Capital, Verve Ventures 11 to 50 Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Manufacturing B2B London, UK •••••••••••@puraffinity.com
LabGenius HIRING

Biopharmaceutical company developing protein therapeutics with a machine learning-driven evolution engine.

43
$3M · Seed Atomico, Kindred Capital, Felicis Ventures 51 to 100 Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing B2B London, UK •••••••••••@labgeni.us
Arborea

Platform that industrializes photosynthesis to increase the global food supply.

43
$4M · Seed Business Growth Fund 1 to 10 Climate Tech & Green Tech, Foodtech, Biotech, Manufacturing B2B London, UK •••••••••••@arborea.io
BioCorteX

Computer simulation to understand drug-bacteria interactions.

43
$5M · Seed Hoxton Ventures, Sofinnova Partners 1 to 10 Biotech London, UK •••••••••••@biocortex.co.uk
Better Dairy

Building the future of food, starting with dairy.

43
$2M · Seed Entrepreneur First, Vorwerk Ventures, CPT Capital 1 to 10 Agritech, Foodtech, Biotech, Manufacturing B2B, B2C London, UK •••••••••••@betterdairy.co.uk
Hoxton Farms

Cultivated fat producer for the meat alternatives industry.

43
$3M · Seed BACKED VC, CPT Capital 11 to 50 Foodtech, Biotech, Manufacturing B2B London, UK •••••••••••@hoxtonfarms.com
NK:IO

Immunotherapy for the treatment of cancer.

43
$1M · Seed Cancer Research Horizons, UK Innovation & Science Seed Fund 11 to 50 Biotech, Pharma B2C London, UK •••••••••••@nk-io.com
Nature Metrics

Developer of cutting-edge DNA techniques to monitor biodiversity.

43
$3M · Seed SYSTEMIQ, BNP Paribas, Triple Point Ventures 11 to 50 Biotech London, UK •••••••••••@naturemetrics.co.uk
Enterprise Therapeutics

Developer of drugs to treat respiratory diseases.

43
$2M · Series A Forbion Capital Partners, Versant Ventures, Imperial Innovations 11 to 50 Health Tech, Biotech London, UK •••••••••••@enterprisetherapeutics.com
Foodsteps

Platform helping the food sector reduce its carbon footprint.

43
$4M Octopus Ventures, Ascension Ventures, Metaplanet Holdings 11 to 50 Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence B2B, SaaS London, UK •••••••••••@foodsteps.earth
FabricNano

Cell-free chemical manufacturer to produce bio-based alternatives

43
$3M · Seed Hoxton Ventures, Atomico, BACKED VC 11 to 50 Biotech B2B London, UK •••••••••••@fabricnano.com
Epsilogen

Immuno-oncology company treats cancer with antibodies.

43
$2M · Series A AlbionVC, Novartis Venture Fund, Epidarex Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics B2B London, UK •••••••••••@epsilogen.com
Epoch Biodesign

Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.

43
$3M · Pre Seed Lowercarbon Capital, Ascension Ventures, BoxGroup 11 to 50 Biotech, Manufacturing B2B London, UK •••••••••••@epochbiodesign.com
Peptone

We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.

43
$2M Hoxton Ventures, Bessemer Venture Partners 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B London, UK •••••••••••@peptone.io
Quaisr

Digital-twin simulator.

43
$3M · Pre Seed Crane Venture Partners 1 to 10 Biotech, Supply Chain & Logistics B2B London, UK •••••••••••@quaisr.io
Bastion Therapeutics

Developer of novel Treg therapies to treat inflammatory disorders.

43
$840k · Pre Seed Deep Science Ventures, Wren Capital 1 to10 Health Tech, Biotech B2C London, UK •••••••••••@bastion-tx.com
Beckley Psytech

Short-duration psychedelic medicines developer for neuropsychiatric conditions.

42
$40M · Series B Leafy Tunnel, ATAI Life Sciences 1 to 10 Biotech, Pharma B2C Oxford, UK •••••••••••@beckleypsytech.com
AstronauTx

Clinical-stage research for alzheimer’s disease.

42
$58M · Series A EQT Partners, UCL Technology Fund, Brandon Capital 1 to 10 Health Tech, Biotech Reading, UK •••••••••••@astronautx.bio
Concert Bio

Platform that helps businesses create optimal microbial communities.

39
$1M · Pre Seed Nucleus Capital 1 to 10 Agritech, Biotech, Business Intelligence B2B, SaaS London, UK •••••••••••@concert.bio
LiliumX

Protein technology platform that finds new bispecific antibodies to treat cancer.

39
$125k · Pre Seed Hoxton Ventures, Y Combinator 1 to 10 Health Tech, Biotech B2B, SaaS London, UK •••••••••••@liliumx.com
Lifebit

Biomedical CloudOS data platform.

39
$120k · Seed Eurazeo, Connect Ventures, Techstars 51 to 100 Health Tech, Biotech, Data and Analytics, Business Intelligence B2B, SaaS London, UK •••••••••••@lifebit.ai
Clustermarket

One lab management platform that brings people, equipment and data together - no matter where they are.

39
$1M Forward Partners 11 to 50 Health Tech, Biotech, Deep Tech B2B, SaaS London, UK •••••••••••@clustermarket.com
Neucruit

Platform enhancing the efficiency, transparency, and diversity of clinical trials.

39
$100k · Pre Seed Atomico, Nina Capital 11 to 50 Health Tech, Biotech, Hiring and Recruitement, Data and Analytics, Community & Lifestyle, Business Intelligence B2B, SaaS London, UK •••••••••••@neucruit.com
Actimed Therapeutics

Developer of innovative treatment for muscle wasting disorders.

39
$1M · Seed Mankind Pharma 1 to 10 Biotech, Pharma London, UK •••••••••••@actimedtherapeutics.com
Gardin

Optical phenotyping technology and analytics optimize food production.

39
$1M · Pre Seed Seedcamp, Molten Ventures, MMC Ventures 11 to 50 Agritech, Foodtech, Biotech, Data and Analytics B2B, SaaS London, UK •••••••••••@gardin.co.uk
Exogene

Biotechnology platform accelerating cancer cell therapy discoveries with AI-driven TCR-antigen screening.

39
$104k · Pre Seed Atomico, Entrepreneur First 1 to 10 Health Tech, AI, Biotech, Deep Tech, Pharma, Data and Analytics B2B London, UK •••••••••••@exogene.co.uk
Nuntius Therapeutics

Platform offering advanced targeted RNA, DNA, and CRISPR therapies.

39
$125k · Pre Seed Y Combinator 1 to 10 Health Tech, Biotech, Deep Tech B2B London, UK •••••••••••@nuntiustx.com
Syrona Health

Platform offering personalized digital health solutions for chronic gynecological conditions like endometriosis and PCOS.

39
$253k · Seed Y Combinator, Katapult Accelerator 1 to 10 Health Tech, Biotech, Deep Tech, Femtech, Ecommerce, ElderTech, Fertility B2B London, UK •••••••••••@syronahealth.com
Shellworks

Biotech startup working to eliminate plastic waste.

39
$820k · Pre Seed Local Globe, Atomico, Ascension Ventures 1 to 10 Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing, Supply Chain & Logistics B2B London, UK •••••••••••@theshellworks.com